Articles by Michael Blackton
Contingency Planning For Quality In The Cell And Gene Sector Due To COVID-19
Maintaining clinical trials during the COVID-19 pandemic has presented quite a challenge for those companies exploring novel therapies.
COVID-19’s Impact On Patient Centricity
Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune cover COVID-19's impact on patient centricity.
Changes To Anticipate In A Post-COVID Climate
In this brief video, Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune discuss changes to anticipate in the post-COVID climate.